Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance &

Status Completed

Clinical Trial Summary

The aim of this study is to evaluate plasma adiponectin level, insulin resistance, cardiovascular risk and their correlation (if any) in patients with hypothyroidism and also to investigate the effect of levothyroxine on these parameters. The study may explore the lacunae in present treatment protocol and can suggest the possibilities of add-on therapies for a better management.

Clinical Trial Description

Hypothyroidism is associated with premature atherosclerosis and increased prevalence of coronary artery diseases. Long-term hypothyroidism is associated with severe cardiovascular manifestations including reduced intravascular volume, increased systemic vascular resistance, and hypertension. Hypothyroidism is one of the main causes of secondary dyslipidemia. The classic manifestations of hypothyroidism are raised VLDL, LDL and apo A. The increase in cardiovascular risk is not only due to dyslipidemia, but also to hemodynamic changes, endothelial dysfunction, hormonal and metabolic changes. Insulin resistance and the metabolic syndrome are important cardiovascular risk factors as insulin-resistant individuals with raised TSH have higher LDL concentrations.

Among the various markers associated with obesity and insulin resistance, of particular importance is adiponectin which is inversely related to the degree of adiposity, increases insulin sensitivity, and has antiatherogenic and anti-inflammatory properties, hence may be cardioprotective. Hypoadiponectinaemia is associated with obesity, insulin resistance and type II diabetes, as well as atherosclerosis, hypertension and coronary artery disease.

Treating hypothyroidism with levothyroxine has an antioxidant and cholesterol reducing effect, and thus already has proven beneficial impact on cardiovascular function, blood pressure and lipid profile. But the association of adiponectin and insulin resistance in hypothyroid state and future cardiovascular risk is still not clear because there are few published studies in this domain and result of some the studies are contradictory. The aim of this study is to evaluate plasma adiponectin level, insulin resistance, cardiovascular risk and their correlation (if any) in patients with hypothyroidism and also to investigate the effect of levothyroxine on these parameters. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02467244
Study type	Observational
Source	All India Institute of Medical Sciences, Bhubaneswar
Contact
Status	Completed
Phase
Start date	February 1, 2017
Completion date	December 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05975866` - The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato	N/A
Not yet recruiting	`NCT05334771` - Early Detection of Endolymphatic Hydrops in Hypothyroid Patients
Withdrawn	`NCT01707056` - The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma	N/A
Completed	`NCT00094237` - Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke	N/A
Recruiting	`NCT06015620` - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed	`NCT03612908` - TSHβX1 and D2 THR92ALA in Pregnancy
Completed	`NCT04782856` - Energy Metabolism in Thyroidectomized Patients	Phase 2
Completed	`NCT01921452` - Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit	Phase 4
Completed	`NCT01197183` - Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France	N/A
Recruiting	`NCT05247476` - Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.	Phase 4
Recruiting	`NCT03754621` - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Completed	`NCT02959827` - Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
Completed	`NCT04124705` - A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants	Phase 2
Withdrawn	`NCT02577367` - Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding	Phase 4
Completed	`NCT04098991` - Improving White Matter Integrity With Thyroid Hormone
Not yet recruiting	`NCT03257566` - Hypothyroidism in Patients With Type 1 Diabetes	N/A
Terminated	`NCT02567877` - Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
Completed	`NCT02280330` - Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months	Phase 4
Completed	`NCT00403390` - Generic vs. Name-Brand Levothyroxine	N/A
Not yet recruiting	`NCT06096454` - Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance	Phase 4

Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms